BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23231713)

  • 1. Management of chronic pulmonary aspergillosis.
    Izumikawa K; Tashiro M; Kohno S
    Ann N Y Acad Sci; 2012 Dec; 1272():40-8. PubMed ID: 23231713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance.
    Takeda K; Suzuki J; Watanabe A; Arai T; Koiwa T; Shinfuku K; Narumoto O; Kawashima M; Fukami T; Tamura A; Nagai H; Matsui H; Kamei K
    Med Mycol; 2021 Apr; 59(4):327-334. PubMed ID: 32642756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic aspergillus infections of the respiratory tract: diagnosis, management and antifungal resistance.
    Izumikawa K; Takazono T; Kohno S
    Curr Opin Infect Dis; 2010 Dec; 23(6):584-9. PubMed ID: 20827190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?
    Snelders E; Melchers WJ; Verweij PE
    Future Microbiol; 2011 Mar; 6(3):335-47. PubMed ID: 21449843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of azole resistant-
    Danion F; Duréault A; Gautier C; Senechal A; Persat F; Bougnoux ME; Givel C; Couderc LJ; Lortholary O; Garcia-Hermoso D; Lanternier F
    J Med Microbiol; 2020 Jun; 69(6):844-849. PubMed ID: 32459615
    [No Abstract]   [Full Text] [Related]  

  • 6. Azole Resistance in Aspergillus fumigatus in Patients with Cystic Fibrosis: A Matter of Concern?
    Hamprecht A; Morio F; Bader O; Le Pape P; Steinmann J; Dannaoui E
    Mycopathologia; 2018 Feb; 183(1):151-160. PubMed ID: 28653258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in chronic pulmonary aspergillosis.
    Izumikawa K
    Respir Investig; 2016 Mar; 54(2):85-91. PubMed ID: 26879477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azole-resistant aspergillosis.
    Warris A
    J Infect; 2015 Jun; 71 Suppl 1():S121-5. PubMed ID: 25917808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus.
    Verweij PE; Ananda-Rajah M; Andes D; Arendrup MC; Brüggemann RJ; Chowdhary A; Cornely OA; Denning DW; Groll AH; Izumikawa K; Kullberg BJ; Lagrou K; Maertens J; Meis JF; Newton P; Page I; Seyedmousavi S; Sheppard DC; Viscoli C; Warris A; Donnelly JP
    Drug Resist Updat; 2015; 21-22():30-40. PubMed ID: 26282594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulsed echinocandin therapy in azole intolerant or multiresistant chronic pulmonary aspergillosis: A retrospective review at a UK tertiary centre.
    Osborne W; Fernandes M; Brooks S; Grist E; Sayer C; Hansell DM; Wilson R; Shah A; Loebinger MR
    Clin Respir J; 2020 Jun; 14(6):571-577. PubMed ID: 32077238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive Aspergillus PCR as a marker of azole resistance or sub-therapeutic antifungal therapy in patients with chronic pulmonary aspergillosis.
    Moazam S; Eades CP; Muldoon EG; Moore CB; Richardson MD; Rautemaa-Richardson R
    Mycoses; 2020 Apr; 63(4):376-381. PubMed ID: 31981256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and experimental phenotype of azole-resistant Aspergillus fumigatus with a HapE splice site mutation: a case report.
    Ito Y; Takazono T; Koga S; Nakano Y; Ashizawa N; Hirayama T; Tashiro M; Saijo T; Yamamoto K; Imamura Y; Miyazaki T; Yanagihara K; Izumikawa K; Mukae H
    BMC Infect Dis; 2021 Jun; 21(1):573. PubMed ID: 34126952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary aspergillosis caused by a pan-azole-resistant Aspergillus fumigatus in a 10-year-old boy.
    Thors VS; Bierings MB; Melchers WJ; Verweij PE; Wolfs TF
    Pediatr Infect Dis J; 2011 Mar; 30(3):268-70. PubMed ID: 21127455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to five antifungals of Aspergillus fumigatus strains isolated from chronically colonised cystic fibrosis patients receiving azole therapy.
    Amorim A; Guedes-Vaz L; Araujo R
    Int J Antimicrob Agents; 2010 Apr; 35(4):396-9. PubMed ID: 20138740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azole resistant Aspergillus fumigatus: an emerging problem.
    Lelièvre L; Groh M; Angebault C; Maherault AC; Didier E; Bougnoux ME
    Med Mal Infect; 2013 Apr; 43(4):139-45. PubMed ID: 23562488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious diseases. Farm fungicides linked to resistance in a human pathogen.
    Enserink M
    Science; 2009 Nov; 326(5957):1173. PubMed ID: 19965440
    [No Abstract]   [Full Text] [Related]  

  • 17. Azole resistance in Aspergillus fumigatus: a growing public health concern.
    Vermeulen E; Lagrou K; Verweij PE
    Curr Opin Infect Dis; 2013 Dec; 26(6):493-500. PubMed ID: 24126719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Level Pan-Azole-Resistant Aspergillosis.
    van Ingen J; van der Lee HA; Rijs AJ; Snelders E; Melchers WJ; Verweij PE
    J Clin Microbiol; 2015 Jul; 53(7):2343-5. PubMed ID: 25903576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Azole-resistant invasive aspergillosis].
    van der Linden JW; Warris A; van der Meer JW; Bresters D; Melchers WJ; Verweij PE
    Ned Tijdschr Geneeskd; 2009; 153():A765. PubMed ID: 20051169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Azole resistance in Aspergillus fumigatus in the Netherlands--increase due to environmental fungicides?].
    Verweij PE; van de Sande-Bruisma N; Kema GH; Melchers WJ
    Ned Tijdschr Geneeskd; 2012; 156(25):A4458. PubMed ID: 22748367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.